-
Inventory -
The acquisition, storing, distribution, and accounting of the intranasal naloxone kit shall follow the process detailed below: -
Only clinic staff who have completed training shall acquire intranasal naloxone from DMH pharmacy headquarters located at 510 S. Vermont Ave, 21st floor, Pharmacy Warehouse, Los Angeles, CA 90020. -
Intranasal naloxone shall either be picked up by authorized staff or delivered to clinic by DMH pharmacy staff. Each box contains the following: -
Two (2) single-dose intranasal spray devices containing 4 mg of naloxone hydrochloride in 0.1 ml (both doses are considered as one unit). -
Administration instructions. -
Authorized personnel shall document inventory as described in the policy in the Naloxone (NARCAN) Distribution Program Log. -
Storage -
Intranasal naloxone shall be stored in a designated cabinet located behind the clinic front desk staff. -
Distribution -
Authorized Personnel shall distribute one to two (1-2) boxes of intranasal naloxone for client use upon client request. If client requests more than 2 boxes, Authorized Personnel shall distribute the requested quantity with documentation of client’s reason for requesting more than 2 boxes in Naloxone (NARCAN) Distribution Program Log. Limit 5 boxes (10 intranasal naloxone devices) per day. -
Documentation -
Inventory Documentation - shall be documented as described above in the Naloxone (NARCAN) Distribution Program Log. -
Intranasal Naloxone Successful Reversal History – shall be documented in the Naloxone (NARCAN) Distribution Program Log after each distribution as described in the policy. | |
|